SCHEMBL12607125

SCHEMBL12607125

CCOC(=O)[C@@H]1CCCCC=CCO[C@@H](C)[C@H](NC(=O)OC(C)(C)C)C(=O)N2C[C@H]3C([C@H]2C(=O)N1)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607130 1.00 — —
SCHEMBL8290714 0.89 NAAA (0.32) —
SCHEMBL8054841 0.87 MEN1 (0.31) —
SCHEMBL12606636 0.82 MEN1 (0.34) —
SCHEMBL12607419 0.80 CTSD (0.35) —
SCHEMBL13684888 0.80 GAA (0.33) —
SCHEMBL13685061 0.80 GAA (0.33) —
SCHEMBL13686196 0.80 GAA (0.33) —
SCHEMBL16349814 0.78 — —
SCHEMBL16349801 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110150835-A1 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease SCHERING CORPORATION 2011-06-23 — — US disclosed
Send feedback